Interleukin-21 (IL-21) plays a pivotal role in shaping the adaptive immune response by enhancing effector T-cell proliferation while simultaneously inhibiting the development of regulatory T (Treg) cells—a critical balance for effective anti-tumor immunity. In this study, IL-21 was shown to synergize with interleukin-2 (IL-2) to drive robust, T-cell receptor (TCR)-dependent expansion of both CD4+ and CD8+ human T cells, particularly in naive subsets. This synergy enables significantly greater T-cell output than achievable with IL-2 alone, offering a potential solution to the dose-limiting toxicities associated with high-dose IL-2 therapy.
The experimental model utilized purified peripheral blood mononuclear cells (PBMCs), including CD25-depleted T cells and sorted naive (CD45RA+) and memory (CD45RO+) subsets. Using fluorescent dye dilution assays (CFSE or CellTrace Violet), researchers tracked cell divisions and quantified proliferative responses. Results demonstrated that IL-21 dramatically amplified IL-2-induced proliferation, especially at low IL-2 concentrations (e.g., 20 U/mL). Even when IL-2 levels were supra-maximal (300 U/mL), adding IL-21 further enhanced CD4+ T-cell expansion, indicating true synergistic interaction rather than simple additivity. While CD8+ T-cell proliferation also increased, the effect was less pronounced, likely due to their inherently higher baseline responsiveness.
A key finding was IL-21’s ability to counteract Treg cell induction driven by IL-2 and transforming growth factor-beta (TGF-β)—two cytokines abundantly present in the tumor microenvironment. In cultures supplemented with IL-2/TGF-β, Treg cell frequencies rose sharply. However, inclusion of IL-21 significantly reduced Treg expansion, particularly in naive CD4+ T cells. Flow cytometric analysis revealed that IL-21 did not prevent the initial conversion of activated naive cells into Tregs but instead suppressed their subsequent proliferation. This was confirmed by comparing the proliferation index (PI) of Treg versus non-Treg cells: IL-2/TGF-β strongly favored Treg expansion, whereas IL-21 reversed this bias, promoting preferential growth of non-Treg populations.
Mechanistically, IL-21 maintained sustained phosphorylation of Stat3—known to inhibit Foxp3 expression and Treg differentiation—while dampening Smad2/3 phosphorylation induced by TGF-β. This dual modulation disrupts the pro-Treg signaling axis without altering the initial activation signals. Notably, IL-21 had no impact on Stat5 phosphorylation, confirming its selective interference with Treg-promoting pathways rather than general T-cell activation.
Contrary to earlier reports, IL-21 failed to neutralize Treg-mediated suppression of responder T-cell proliferation.Bcl-2 Antibody Autophagy In co-culture assays, autologous Tregs effectively suppressed proliferation regardless of IL-21 presence.Terutroban Description This suggests that IL-21 does not function as a direct inhibitor of Treg suppressive activity but rather prevents their accumulation in the first place.PMID:34796915
These results underscore IL-21’s unique value in cancer immunotherapy: it enhances effector T-cell expansion while actively restraining the formation of immunosuppressive Treg cells. By enabling lower doses of IL-2 to achieve potent T-cell responses, the IL-2/IL-21 combination may reduce systemic toxicity and improve clinical outcomes. Furthermore, targeting Treg development through proliferation blockade offers a more sustainable alternative to transient depletion strategies, which often lead to rapid re-emergence of Tregs. Together, these findings provide strong preclinical support for integrating IL-21 into combinatorial immunotherapies aimed at breaking immune tolerance in cancer.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com